The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Akebia Therapeutics, Inc(NASDAQ:AKBA) 
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the tre...
Akebia Therapeutics Days Payable Outstanding ttm (DPO)
Akebia Therapeutics Days Receivable Outstanding ttm (DSO)
Akebia Therapeutics Days Inventory Outstanding ttm (DIO)
Akebia Therapeutics Op Cashflow Per Share ttm
Akebia Therapeutics Free Cashflow Per Share ttm
Akebia Therapeutics Cash Per Share ttm
Akebia Therapeutics P/S ratio ttm
Akebia Therapeutics (GAAP) P/E ratio ttm
Akebia Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.